The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design

被引：0
|
作者：
Rikke Mette Agesen
Amra Ciric Alibegovic
Henrik Ullits Andersen
Henning Beck-Nielsen
Peter Gustenhoff
Troels Krarup Hansen
Christoffer Hedetoft
Tonny Jensen
Claus Bogh Juhl
Susanne Søgaard Lerche
Kirsten Nørgaard
Hans-Henrik Parving
Lise Tarnow
Birger Thorsteinsson
Ulrik Pedersen-Bjergaard
机构：
[1] Nordsjællands Hospital,Department of Endocrinology and Nephrology
[2] Steno Diabetes Center Copenhagen,Department of Endocrinology M
[3] Odense University Hospital,Faculty of Health Sciences
[4] University of Southern Denmark,Department of Endocrinology
[5] Aalborg University Hospital,Department of Medical Endocrinology
[6] Steno Diabetes Center Aarhus,Department of Diabetes and Hormonal Diseases
[7] Health,Department of Endocrinology
[8] University of Aarhus,Department of Clinical Research
[9] Department of Internal Medicine,Faculty of Health and Medical Sciences
[10] Copenhagen University Hospital (Rigshospitalet),undefined
[11] Department of Medicine,undefined
[12] Sydvestjysk Sygehus,undefined
[13] Lillebælt Hospital Kolding,undefined
[14] Hvidovre University Hospital,undefined
[15] Nordsjællands Hospital,undefined
[16] Steno Diabetes Center Sjaelland,undefined
[17] University of Copenhagen,undefined
来源：
BMC Endocrine Disorders | / 19卷
关键词：
Type 1 diabetes; Nocturnal hypoglycaemia; Severe hypoglycaemia; Insulin degludec; Insulin glargine; RCT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 34 条
  • [21] Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia
    Brosen, Julie Maria Boggild
    Agesen, Rikke Mette
    Alibegovic, Amra Ciric
    Andersen, Henrik Ullits
    Beck-Nielsen, Henning
    Gustenhoff, Peter
    Hansen, Troels Krarup
    Hedetoft, Christoffer Georg Riber
    Jensen, Tonny Joran
    Stolberg, Charlotte Ron
    Juhl, Claus Bogh
    Lerche, Susanne Sogaard
    Norgaard, Kirsten
    Parving, Hans-Henrik
    Tarnow, Lise
    Thorsteinsson, Birger
    Pedersen-Bjergaard, Ulrik
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (09) : 643 - 654
  • [22] The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes
    M. K. Bulsara
    C. D. J. Holman
    F. M. van Bockxmeer
    E. A. Davis
    P. H. Gallego
    J. P. Beilby
    L. J. Palmer
    C. Choong
    T. W. Jones
    Diabetologia, 2007, 50 : 965 - 971
  • [23] The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes
    Bulsara, M. K.
    Holman, C. D. J.
    van Bockxmeer, F. M.
    Davis, E. A.
    Gallego, P. H.
    Beilby, J. P.
    Palmer, L. J.
    Choong, C.
    Jones, T. W.
    DIABETOLOGIA, 2007, 50 (05) : 965 - 971
  • [24] Sustained glycaemic control and less nocturnal hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 1 diabetes (EDITION JP 1 randomised 12-month trial including 6-month extension)
    Matsuhisa, Munehide
    Koyama, Masayoshi
    Cheng, Xi
    Sumi, Mariko
    Riddle, Matthew C.
    Bolli, Geremia B.
    Hirose, Takahisa
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 122 : 133 - 140
  • [25] Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)
    Pollock, Richard F.
    Heller, Simon
    Pieber, Thomas R.
    Woo, Vincent
    Gundgaard, Jens
    Hallen, Nino
    Luckevich, Maria
    Tutkunkardas, Deniz
    Zinman, Bernard
    DIABETES OBESITY & METABOLISM, 2019, 21 (07) : 1706 - 1714
  • [26] Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested case-control study
    Settles, Julie
    Kan, Hong
    Child, Christopher J.
    Gorritz, Magdaliz
    Multani, Jasjit K.
    McGuiness, Catherine B.
    Wade, Rolin L.
    Frier, Brian M.
    DIABETES OBESITY & METABOLISM, 2022, 24 (07) : 1235 - 1244
  • [27] Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetes
    Pieber, Thomas R.
    Aronson, Ronnie
    Christiansen, Mark P.
    Bode, Bruce
    Junaidi, Khaled
    Conoscenti, Valentina
    DIABETES OBESITY & METABOLISM, 2022, 24 (07) : 1394 - 1397
  • [28] Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study
    Taner Damci
    Rifat Emral
    Anne Louise Svendsen
    Tanzer Balkir
    Jiten Vora
    BMC Endocrine Disorders, 14
  • [29] Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study
    Damci, Taner
    Emral, Rifat
    Svendsen, Anne Louise
    Balkir, Tanzer
    Vora, Jiten
    BMC ENDOCRINE DISORDERS, 2014, 14
  • [30] HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial
    Stefanie MPA Rondags
    Maartje de Wit
    Maurits W van Tulder
    Michaela Diamant
    Frank J. Snoek
    BMC Endocrine Disorders, 15
1234